Science News

(University of New South Wales) UNSW Australia's solar researchers have converted over 40 percent of the sunlight hitting a solar system into electricity, the highest efficiency ever reported.

The start of alcohol consumption, the missing y chromosome and even the auction of a corpse plate are just a few of this weeks cool science stories.

UNSW Australia's solar researchers have converted over 40% of the sunlight hitting a solar system into electricity, the highest efficiency ever reported.

Not long ago, I attended two tech conferences. AI, robotics, nanotechnology, and biotechnology--both were future focused. But the most curious thing I saw there wasn't on stage. It was more...

HAVANA/GENEVA

Recognizing that leukemia cannot be conquered with a 'one-size-fits-all' approach, researchers are pursuing novel targeted therapies and combinations of existing treatment regimens with new agents for patient populations...

Anti-epileptic drugs control seizures and improve quality of life for most people with epilepsy. But for those who find medical treatment ineffective or intolerable, brain surgery is sometimes the next best option. Two s...

New findings from a phase 3 clinical trial suggest an additional therapeutic option may be coming down the pike. Researchers performed a randomized, double-blind, placebo-controlled study in the United States and Europe ...

The 'molecular mail' sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a new study.

In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team.

In a late-stage clinical trial, Hodgkin lymphoma patients who received brentuximab vedotin post-transplant lived longer without disease progression than patients who received only supportive care, researchers report.

In recent years, a number of scientific breakthroughs have led to the development of drugs that unleash the power of the immune system to recognize and attack cancer. For Classical Hodgkin lymphoma patients, two phase I ...

An innovative therapy against a highly aggressive leukemia continues to show highly promising results in children treated in a pilot study. Of 39 children receiving bioengineered T cells, 92 percent had no evidence of ca...

The reliability of optogenetics as a method of intervention of temporal lobe seizures, and the role the cerebellum may play in hippocampal function and seizure reduction, have been the focus of recent study. Optogenetics...

A pair of studies provides innovative insights into the genetic underpinnings of childhood epilepsies. Technological advances in genetic analysis have uncovered changes in single genes that account for a surprising numbe...